The hapten-binding myelomas of BALB/c mice provide monoclonal populations of antigen-binding B cells that are responsive to immunoregulatory effectors induced in tumor-bearing hosts. Specific, immunological regulation of myeloma cell proliferation, differentiation, and immunoglobulin expression demonstrates many of the features that occur in T cell-mediated regulation of nonneoplastic antigen-binding B cells. Immunoregulation of MOPC-315 cell proliferation and immunoglobulin expression can be induced by: (1) immune response directed to the idiotypic antigens of M315 and (2) carrier specific presentation of TNP to the cell surface membrane TNP receptor of MOPC-315 celIs in carrier-primed syngeneic hosts. Immunization of BALB/c with M315 induces two distinct suppressor T-cell populations. One population mediates a cytostatic effect on MOPC-315 proliferation, and the other population inhibits M315 synthesis and secretion. In the past year, we have shown that inhibition of synthesis results from a specific and reversible suppression of light chain mRNA expression in MOPC-315 cells. We have shown that inhibition of synthesis results from a specific and reversible suppression of light chain mRNA expression in MOPC-315 cells. In the past year we have constructed a number of double-producing myeloma clones by fusing two different hapten-binding myeloma clones and selecting double-producers. This has generated a library of clones in which the partner immunoglobulins express the same or different heavy and/or light chains. In addition, kappa light chain genes have been successfully transfected into MOPC-315 cells to generate clones in which a constitutive lambda?2? light chain and the vectored kappa light chain are coexpressed. These cells will be examined to determine if light chain depression is light chain-class specific. The major objective of these studies is to develop an understanding of the immunological mechanisms that regulate the growth and differentiation of normal and neoplastic B cells. (IP)

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA032275-05
Application #
3170260
Study Section
Pathology B Study Section (PTHB)
Project Start
1981-07-01
Project End
1986-03-31
Budget Start
1985-04-01
Budget End
1986-03-31
Support Year
5
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of Iowa
Department
Type
Schools of Medicine
DUNS #
041294109
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Waldschmidt, T J; Conrad, D H; Lynch, R G (1988) The expression of B cell surface receptors. I. The ontogeny and distribution of the murine B cell IgE Fc receptor. J Immunol 140:2148-54
Lynch, R G; Mathur, A; Waldschmidt, T J et al. (1988) Immunoglobulin (Fc) receptors on murine T- and B-lymphocytes: investigations using tumor models. Mol Immunol 25:1151-7
Lynch, R G (1988) Immunology of lymphoid cancer: probing of tumours and tumours as probes. Ann Inst Pasteur Immunol 139:71-83
Urnovitz, H B; Chang, Y; Scott, M et al. (1988) IgA:IgM and IgA:IgA hybrid hybridomas secrete heteropolymeric immunoglobulins that are polyvalent and bispecific. J Immunol 140:558-63
Mathur, A; Lynch, R G; Kohler, G (1988) Expression, distribution and specificity of Fc receptors for IgM on murine B cells. J Immunol 141:1855-62